
Class Action Filed Following Artificial Tears Recall, Says Eye Drops Pose 'Serious and Dangerous Health Risk'
The companies behind EzriCare- and Delsam Pharma-brand Artificial Tears face a proposed class action lawsuit less than a week after the eye drops were voluntarily recalled over concerns the products could be contaminated with potentially deadly bacteria.